IEC 2021 Symposium: A practical approach: Epilepsy misdiagnosis in clinical practice
View key takeaways from the IEC 2021 Symposium, sponsored by PTC Therapeutics, which discusses the differential diagnosis of aromatic L-amino acid decarboxylase (AADC) deficiency and how to recognize the red flag signs and symptoms in clinical practice
Recognize the challenges associated with differential diagnosis of neurotransmitter disorders, particularly those presenting with epileptic signs and symptoms, with a focus on AADC deficiency
Using a clinical case study, understand the red flags for AADC deficiency in clinical practice to aid early identification of this rare disease
Find out about the key role of carers and the importance of early diagnosis for families and caregivers of patients with AADC deficiency
This virtual symposium was developed and funded by PTC Therapeutics at the 2021 IEC Congress. It was not part of the official program of IEC 2021.
Register now to unlock the content
Register now to access the content on this page
Already registered?
If not, register below
US-AADC-0496 | June 2022
Sign in or register to access exclusive content on this site
Register here to access the content on the site US-CORP-0330 | July 2022
You are now leaving MEDhub, a website provided by PTC Therapeutics. This link will take you to a website to which our Privacy Statement and our Terms and Conditions do not apply.
We encourage you to read the Privacy Policy and the Terms and Conditions of every website you visit. PTC Therapeutics does not endorse and/or influence the content found on websites not owned/operated by PTC Therapeutics.
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.